Recently, an interview article featuring our company's Asia Regional Divisional Director was published in "CEO Magazine." Customers are facing various challenges in the manufacturing processes of biopharmaceuticals, beverages, food, and chemicals. As the market changes daily, we discuss how we leverage our knowledge and experience in fluid technology to create a system that meets our customers' needs.

Watson-Marlow Co., Ltd., a Japanese corporation, obtained ISO-9001 certification in June 2022.

The overall message of the WMFTG brewing trends report, which includes contributions from the International Centre of Brewing Science, focuses on how brewers can enhance their competitiveness without compromising process efficiency. WMFTG provides sign pump and tube pump technologies that achieve maximum production uptime, meeting the hygiene quality control standards demanded by many of the world's largest and most renowned brands in the brewing industry. This report focuses on investment decisions in the brewing sector and helps justify them. Rod White, an associate professor at the University of Nottingham's International Centre of Brewing Science and a master brewer, states: "For breweries to maintain competitiveness, they must be able to brew a wide range of beer styles while maintaining high operational efficiency. The pressure to produce high-quality beer at low costs is increasing year by year. This report examines some of the key changes occurring in the global industry and explores some of the trends that will emerge in the coming years. I hope this report will be helpful to people."

The pharmaceutical industry is facing significant challenges. Between 1960 and 2000, the world population more than doubled. Advances in medicine, new drug development, and diagnostic technologies have dramatically increased the average lifespan in developed countries. As people live longer, the number of patients with chronic and complex health conditions, such as heart disease, Alzheimer's disease, and type 2 diabetes, has also risen. The rising costs of treating these increasing numbers of patients are putting pressure on healthcare systems, and the medical community expects pharmaceutical companies to supply medical products at lower prices. In response, pharmaceutical manufacturers are exploring new processes and manufacturing techniques that can help reduce the costs of pharmaceutical products. Since the 1970s, the industry has been seeking concepts for production enhancement. Through new technologies and process methodologies, production enhancement aims to shorten timelines, improve efficiency, and reduce costs. Among the increasingly adopted methods is perfusion cell culture, also known as upstream continuous culture. The latest white paper titled "Pursuit of Efficiency - Transition to Continuous Processes," published by the National Institute for Bioprocessing Research and Training (NIBRT) and Watson-Marlow, discusses the benefits of continuous processes in pharmaceutical manufacturing.